Lataa...
Interleukin-12 Therapy Reduces the Number of Immune Cells and Pathology in Lungs of Mice Infected with Mycobacterium tuberculosis
Alternate modalities for the treatment of Mycobacterium tuberculosis are needed due to the rise in numbers of immunosuppressed individuals at risk for serious disease and the increasing prevalence of multidrug-resistant isolates. Interleukin-12 (IL-12) has been shown to improve immune responses agai...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2004
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC387906/ https://ncbi.nlm.nih.gov/pubmed/15102810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.72.5.2976-2988.2004 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|